Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Keller, MD
Children's National Research Institute
Study Chair - Michael Pulsipher, MD
Children's Hospital Los Angeles
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- City of Hope
Duarte, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- University of California, Los Angeles
Los Angeles, California, United States
- Stanford Lucile Packard Children'S Hospital
Palo Alto, California, United States
- Ucsf Medical Center
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Yale
New Haven, Connecticut, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Emory University/children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Riley Hospital for Children - Indiana University
Indianapolis, Indiana, United States
- Dana-Farber Cancer Institute/ Boston Children'S Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Spectrum Health - Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Oregon Health & Science University
Portland, Oregon, United States
- the Children'S Hospital
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- St. Jude
Memphis, Tennessee, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
- Children'S Mercy
San Antonio, Texas, United States
- Methodist Healthcare System of San Antonio
San Antonio, Texas, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
- Fred Hutchinson Cancer Research Center/seattle Chlindren'S/university of Washington School of Medicine
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jun 2018
- Primary completion
- 30 Jun 2025
- Completion
- 30 Jun 2025
- Last update posted
- 11 May 2025
- Registered enrollment
- 52
- Registry id
- NCT03475212
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.